Thefluorescence intensity and respective areas of tumor involvement is higher inFigure 5 (from vincristine-treatedmammary carcinoma), when compared to Figures4 and 6, from rats treated withACE and ACE+vincristine 50% respectively. The gene discussed is ACE; the disease is carcinoma.